| 0.004 |
Cardiovascular Diseases |
NA |
BeFree,LHGDN |
|
Detail |
| 0.003 |
intrahepatic cholestasis |
NA |
LHGDN |
|
Detail |
| <0.001 |
colorectal carcinoma |
NA |
BeFree |
|
Detail |
| <0.001 |
Coronary Arteriosclerosis |
NA |
BeFree |
|
Detail |
| <0.001 |
Coronary heart disease |
NA |
BeFree |
|
Detail |
| <0.001 |
Decreased Libido |
NA |
BeFree |
|
Detail |
| <0.001 |
Presenile dementia |
NA |
BeFree |
|
Detail |
| <0.001 |
Mental Depression |
NA |
BeFree |
|
Detail |
| <0.001 |
depressive disorder |
NA |
BeFree |
|
Detail |
| 0.002 |
Diabetes |
The plasma level of sex hormone binding globulin (SHBG), a glycoprotein produced... |
BeFree |
25226295 |
Detail |
| 0.002 |
Diabetes |
Steroid Sex Hormones, Sex Hormone-Binding Globulin, and Diabetes Incidence in th... |
BeFree |
26200237 |
Detail |
| 0.002 |
diabetes mellitus |
The plasma level of sex hormone binding globulin (SHBG), a glycoprotein produced... |
BeFree |
25226295 |
Detail |
| 0.002 |
diabetes mellitus |
Steroid Sex Hormones, Sex Hormone-Binding Globulin, and Diabetes Incidence in th... |
BeFree |
26200237 |
Detail |
| 0.128 |
Diabetes Mellitus, Non-Insulin-Dependent |
These findings provide a potential mechanism to explain why low SHBG predicts th... |
BeFree,CTD_human,GAD |
25226295 |
Detail |
| <0.001 |
Down syndrome |
NA |
BeFree |
|
Detail |
| 0.003 |
Endocrine System Diseases |
NA |
BeFree,GAD |
|
Detail |
| 0.007 |
Endometrial Neoplasms |
NA |
GAD,LHGDN |
|
Detail |
| <0.001 |
Eosinophilia |
NA |
BeFree |
|
Detail |
| <0.001 |
Fatty Liver |
NA |
BeFree |
|
Detail |
| <0.001 |
fragile X syndrome |
NA |
BeFree |
|
Detail |
| 0.003 |
gonadal dysgenesis |
NA |
LHGDN |
|
Detail |
| <0.001 |
gynecomastia |
NA |
BeFree |
|
Detail |
| <0.001 |
Heart Diseases |
NA |
BeFree |
|
Detail |
| <0.001 |
hemochromatosis |
NA |
BeFree |
|
Detail |
| <0.001 |
hyperglycemia |
NA |
BeFree |
|
Detail |
| 0.003 |
hyperinsulinism |
NA |
BeFree,GAD |
|
Detail |
| 0.003 |
Hyperplasia |
NA |
LHGDN |
|
Detail |
| 0.001 |
Hypertensive disease |
NA |
BeFree |
|
Detail |
| <0.001 |
hyperthyroidism |
NA |
BeFree |
|
Detail |
| <0.001 |
hypothyroidism |
NA |
BeFree |
|
Detail |
| 0.002 |
infertility |
NA |
GAD |
|
Detail |
| 0.002 |
Female infertility |
NA |
GAD |
|
Detail |
| 0.003 |
male infertility |
NA |
BeFree,GAD |
|
Detail |
| 0.005 |
Insulin resistance |
NA |
GAD |
|
Detail |
| <0.001 |
Klinefelter syndrome |
NA |
BeFree |
|
Detail |
| 0.003 |
kwashiorkor |
NA |
LHGDN |
|
Detail |
| <0.001 |
Fibroid Tumor |
NA |
BeFree |
|
Detail |
| 0.002 |
liver cirrhosis |
NA |
GAD |
|
Detail |
| <0.001 |
Liver neoplasms |
NA |
BeFree |
|
Detail |
| 0.002 |
Chronic Obstructive Airway Disease |
NA |
GAD |
|
Detail |
| 0.003 |
Lupus Erythematosus, Systemic |
NA |
BeFree,GAD |
|
Detail |
| 0.120 |
Lymphatic Metastasis |
NA |
CTD_human |
|
Detail |
| <0.001 |
lymphoma |
NA |
BeFree |
|
Detail |
| 0.002 |
Lymphoma, Non-Hodgkin |
NA |
GAD |
|
Detail |
| <0.001 |
Malignant neoplasm of stomach |
NA |
BeFree |
|
Detail |
| <0.001 |
Metabolic Diseases |
NA |
BeFree |
|
Detail |
| 0.120 |
Neoplasm Invasiveness |
NA |
CTD_human |
|
Detail |
| 0.003 |
obesity |
NA |
BeFree |
|
Detail |
| 0.002 |
oligospermia |
NA |
GAD |
|
Detail |
| 0.003 |
osteoporosis |
NA |
BeFree,LHGDN |
|
Detail |
| 0.002 |
Osteoporosis, Postmenopausal |
NA |
GAD |
|
Detail |
| 0.002 |
ovarian carcinoma |
NA |
BeFree |
|
Detail |
| 0.006 |
Ovarian Diseases |
NA |
BeFree |
|
Detail |
| <0.001 |
Paresis |
NA |
BeFree |
|
Detail |
| <0.001 |
Pituitary Diseases |
NA |
BeFree |
|
Detail |
| 0.039 |
polycystic ovary syndrome |
Furthermore, this polymorphism was significantly associated with decreased 2-hou... |
BeFree,GAD,LHGDN |
25956367 |
Detail |
| 0.120 |
Prostatic Neoplasms |
NA |
CTD_human |
|
Detail |
| 0.002 |
Precocious Puberty |
NA |
GAD |
|
Detail |
| <0.001 |
schizophrenia |
NA |
BeFree |
|
Detail |
| <0.001 |
Seizures |
NA |
BeFree |
|
Detail |
| 0.002 |
Stomach Neoplasms |
NA |
GAD |
|
Detail |
| <0.001 |
Tachycardia |
NA |
BeFree |
|
Detail |
| <0.001 |
Androgen-Insensitivity Syndrome |
NA |
BeFree |
|
Detail |
| <0.001 |
Turner syndrome |
NA |
BeFree |
|
Detail |
| <0.001 |
Uterine Fibroids |
NA |
BeFree |
|
Detail |
| <0.001 |
Ichthyosis, X-Linked |
NA |
BeFree |
|
Detail |
| <0.001 |
Peripheral Vascular Diseases |
NA |
BeFree |
|
Detail |
| 0.003 |
gestational diabetes |
NA |
BeFree,LHGDN |
|
Detail |
| <0.001 |
Ovarian Failure, Premature |
NA |
BeFree |
|
Detail |
| <0.001 |
Alcohol abuse |
NA |
BeFree |
|
Detail |
| <0.001 |
Muscle Weakness |
NA |
BeFree |
|
Detail |
| <0.001 |
Malignant neoplasm of gallbladder |
NA |
BeFree |
|
Detail |
| <0.001 |
Malignant neoplasm of testis |
NA |
BeFree |
|
Detail |
| <0.001 |
Disorder of endocrine ovary |
NA |
BeFree |
|
Detail |
| <0.001 |
allergic asthma |
NA |
BeFree |
|
Detail |
| <0.001 |
endometriosis of ovary |
NA |
BeFree |
|
Detail |
| 0.003 |
hyperandrogenism |
NA |
BeFree,GAD |
|
Detail |
| <0.001 |
hepatoblastoma |
NA |
BeFree |
|
Detail |
| <0.001 |
Carcinoma, Endometrioid |
NA |
BeFree |
|
Detail |
| <0.001 |
Cystadenocarcinoma, Mucinous |
NA |
BeFree |
|
Detail |
| <0.001 |
Cystadenocarcinoma, Serous |
NA |
BeFree |
|
Detail |
| <0.001 |
diastrophic dysplasia |
NA |
BeFree |
|
Detail |
| <0.001 |
gallbladder carcinoma |
NA |
BeFree |
|
Detail |
| 0.120 |
Erectile dysfunction |
NA |
CTD_human |
|
Detail |
| 0.002 |
Malignant neoplasm of lung |
NA |
GAD |
|
Detail |
| <0.001 |
Ambiguous genitalia |
NA |
BeFree |
|
Detail |
| <0.001 |
Pseudovaginal Perineoscrotal Hypospadias |
NA |
BeFree |
|
Detail |
| <0.001 |
Gitelman syndrome |
NA |
BeFree |
|
Detail |
| <0.001 |
hypogonadotropic hypogonadism |
NA |
BeFree |
|
Detail |
| <0.001 |
Squamous cell carcinoma of esophagus |
NA |
BeFree |
|
Detail |
| <0.001 |
Iron Overload |
NA |
BeFree |
|
Detail |
| <0.001 |
cervix carcinoma |
NA |
BeFree |
|
Detail |
| <0.001 |
Hyperthyroxinemia, familial dysalbuminemic |
NA |
BeFree |
|
Detail |
| <0.001 |
Idiopathic hirsutism |
NA |
BeFree |
|
Detail |
| <0.001 |
Precocious pubarche |
NA |
BeFree |
|
Detail |
| 0.014 |
Malignant neoplasm of prostate |
NA |
BeFree,GAD |
|
Detail |
| <0.001 |
Klinefelter's syndrome - male with more than two X chromosomes |
NA |
BeFree |
|
Detail |
| 0.005 |
endometrial carcinoma |
NA |
BeFree,GAD |
|
Detail |
| <0.001 |
dementia |
NA |
BeFree |
|
Detail |
| <0.001 |
Intraocular pressure disorder |
NA |
BeFree |
|
Detail |
| 0.023 |
Malignant neoplasm of breast |
Implications of gene-environment interaction in studies of gene variants in brea... |
BeFree |
16982738 |
Detail |
| 0.008 |
breast carcinoma |
Implications of gene-environment interaction in studies of gene variants in brea... |
BeFree |
16982738 |
Detail |
| <0.001 |
Carcinogenesis |
NA |
BeFree |
|
Detail |
| 0.003 |
prostate carcinoma |
NA |
BeFree |
|
Detail |
| <0.001 |
Hot flushes |
NA |
BeFree |
|
Detail |
| <0.001 |
Activated Protein C Resistance |
NA |
BeFree |
|
Detail |
| 0.002 |
hepatopulmonary syndrome |
NA |
GAD |
|
Detail |
| 0.003 |
Epithelial ovarian cancer |
NA |
BeFree,GAD |
|
Detail |
| 0.008 |
breast carcinoma |
NA |
BeFree |
|
Detail |
| <0.001 |
Secondary malignant neoplasm of lymph node |
NA |
BeFree |
|
Detail |
| <0.001 |
stomach carcinoma |
NA |
BeFree |
|
Detail |
| 0.002 |
Carcinoma of bladder |
To establish the relationship between acrolein and 4-ABP exposure and BC, we ana... |
BeFree |
24939871 |
Detail |
| <0.001 |
Testicular malignant germ cell tumor |
NA |
BeFree |
|
Detail |
| <0.001 |
Chronic graft-versus-host disease |
NA |
BeFree |
|
Detail |
| 0.003 |
ovarian neoplasm |
NA |
BeFree,LHGDN |
|
Detail |
| <0.001 |
Testicular Feminization |
NA |
BeFree |
|
Detail |
| 0.002 |
Malignant neoplasm of ovary |
NA |
BeFree |
|
Detail |
| <0.001 |
endometrial adenocarcinoma |
NA |
BeFree |
|
Detail |
| <0.001 |
Eosinophilic disorder |
NA |
BeFree |
|
Detail |
| <0.001 |
Sporadic Breast Carcinoma |
NA |
BeFree |
|
Detail |
| 0.014 |
Mammary Neoplasms |
NA |
LHGDN |
|
Detail |
| <0.001 |
Hepatocarcinogenesis |
NA |
BeFree |
|
Detail |
| <0.001 |
colorectal cancer |
NA |
BeFree |
|
Detail |
| <0.001 |
Adenocarcinoma, Endometrioid |
NA |
BeFree |
|
Detail |
| <0.001 |
Disorder characterized by eosinophilia |
NA |
BeFree |
|
Detail |
| <0.001 |
THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE (disorder) |
NA |
BeFree |
|
Detail |
| 0.002 |
uterine corpus cancer |
NA |
BeFree |
|
Detail |
| 0.008 |
coronary artery disease |
NA |
BeFree,GAD,LHGDN |
|
Detail |
| 0.004 |
liver carcinoma |
NA |
BeFree,LHGDN |
|
Detail |
| <0.001 |
Steatohepatitis |
NA |
BeFree |
|
Detail |
| <0.001 |
Placental Steroid Sulfatase Deficiency |
NA |
BeFree |
|
Detail |
| <0.001 |
thyroid hormone resistance syndrome |
NA |
BeFree |
|
Detail |
| <0.001 |
5-Alpha Reductase Deficiency |
NA |
BeFree |
|
Detail |
| 0.002 |
Abortion, Habitual |
NA |
GAD |
|
Detail |
| <0.001 |
adenocarcinoma |
NA |
BeFree |
|
Detail |
| 0.120 |
Alcoholic Intoxication, Chronic |
NA |
CTD_human |
|
Detail |
| <0.001 |
Alzheimer's disease |
NA |
BeFree |
|
Detail |
| 0.003 |
anorexia nervosa |
NA |
LHGDN |
|
Detail |
| <0.001 |
arteriosclerosis |
NA |
BeFree |
|
Detail |
| <0.001 |
rheumatoid arthritis |
NA |
BeFree |
|
Detail |
| <0.001 |
atherosclerosis |
NA |
BeFree |
|
Detail |
| 0.002 |
autistic disorder |
NA |
GAD |
|
Detail |
| <0.001 |
Benign Ovarian Neoplasm |
NA |
BeFree |
|
Detail |
| <0.001 |
beta thalassemia |
NA |
BeFree |
|
Detail |
| 0.004 |
Malignant neoplasm of urinary bladder |
To establish the relationship between acrolein and 4-ABP exposure and BC, we ana... |
BeFree,GAD |
24939871 |
Detail |
| <0.001 |
Bladder Neoplasm |
To establish the relationship between acrolein and 4-ABP exposure and BC, we ana... |
BeFree |
24939871 |
Detail |
| 0.023 |
Malignant neoplasm of breast |
NA |
BeFree,GAD |
|
Detail |
| 0.002 |
Malignant neoplasm of endometrium |
NA |
BeFree |
|
Detail |
